TECOS

A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (TECOS)

Stage
klaar
Medicine
Sitagliptin
Population
ASCVD
Phase
III
First Patient In
15 November 2008
Last Patient In
1 May 2012
Last Patient Last Visit
-

Study Director

prof. dr. J.H. Cornel

Cardioloog

The page has expired.